Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Upendra P. Hegde"'
Autor:
Sarah Kamsiah Zemlok, BA, Sulaikha Buuh, BA, Regina Brown, MD, MPH, Michael Murphy, MD, Upendra P. Hegde, MD, Janelle R. Mallett, MD, MBA
Publikováno v:
JAAD Case Reports, Vol 38, Iss , Pp 23-26 (2023)
Externí odkaz:
https://doaj.org/article/220daec0636241a8818e7ef4611a435b
Autor:
Aaron N. Holmes, Helen Swede, Wendy M. Feer, Donna Comins Pike, Xiaoyan Wang, Upendra P. Hegde
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Immune-related adverse events (irAEs) are a major toxicity of immune checkpoint inhibitors. Studies have reported that pre-existing autoimmunity increases the risk of irAEs, but it remains unknown which clinical factors are linked
Externí odkaz:
https://doaj.org/article/af3a63eacc4044b9976770070309804f
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 6, Iss , Pp 100154- (2022)
High-risk human papillomavirus (HR HPV) is associated with oropharyngeal squamous cell carcinoma (OPSCC), which is rising. Although the association and mechanism of viral carcinogenesis are well established, the exact risk and time of cancer developm
Externí odkaz:
https://doaj.org/article/ba64d76c8cf34d27af124ab04987f746
Autor:
Nerea Lopetegui Lia, Abigael Luke, Syed Daniyal Asad, Shashank Sama, Leo J. Wolansky, Upendra P. Hegde
Publikováno v:
Clinical Case Reports, Vol 8, Iss 11, Pp 2148-2151 (2020)
Abstract It is important to obtain coagulation tests to assess bleeding risk in trauma patients undergoing emergency surgery when a bleeding disorder may be obscured. Identifying specific clotting factor defects is critical in successful patient mana
Externí odkaz:
https://doaj.org/article/2c95a3b40cdb4e3b9497d07dc9297f87
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:1806-1809
Introduction Salivary gland neoplasms (SGNs) respond poorly to the traditional chemotherapy agents limiting the availability of systemic treatment options in the metastatic setting. The recent identification of actionable molecular targets in SGNs ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aa48b28c4f34b2e80604414410a0dcf
https://doi.org/10.1177/10781552211032722
https://doi.org/10.1177/10781552211032722
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:207-211
Introduction Immune agents including anti-programmed death receptor-1 and anti-cytotoxic T-lymphocyte antigen-4 have been associated with numerous immune-related complications. Pembrolizumab, a programmed death-1 inhibitor, has been associated with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2812199f78b5f22f87825b0756819741
https://doi.org/10.1177/1078155220921543
https://doi.org/10.1177/1078155220921543
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Background Immune-related adverse events (irAEs) are a major toxicity of immune checkpoint inhibitors. Studies have reported that pre-existing autoimmunity increases the risk of irAEs, but it remains unknown which clinical factors are linked to auto-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb086cb089f087e9c2f538bbd9f1df0b
http://europepmc.org/articles/PMC8647353
http://europepmc.org/articles/PMC8647353
Publikováno v:
Journal of Clinical Oncology. 40:e21514-e21514
e21514 Background: Tumor infiltrating lymphocytes (TILs) in the tumor microenvironment generate anti-tumor immunity and are associated with response to immune checkpoint inhibitor (ICI) therapy of melanoma. However, likelihood of response to ICI ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d6e4edc03b0f6d4d90e965c80dac106
https://doi.org/10.1200/jco.2022.40.16_suppl.e21514
https://doi.org/10.1200/jco.2022.40.16_suppl.e21514
Autor:
Amanda K. Dupuy, Bo-Young Hong, Linda D. Strausbaugh, Upendra P. Hegde, Andrew L. Salner, A. Cardenas, Anilei Hoare, Linda Choquette, Anna Dongari-Bagtzoglou, Douglas E. Peterson, Patricia I. Diaz, Peter K. Schauer
Publikováno v:
J Dent Res
A broad range of fungi has been detected in molecular surveys of the oral mycobiome. However, knowledge is still lacking on interindividual variability of these communities and the ecologic and clinical significance of oral fungal commensals. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f3e686cd4e4eb9d489faaffa1962b3
https://europepmc.org/articles/PMC7243416/
https://europepmc.org/articles/PMC7243416/
Autor:
Upendra P. Hegde, Bijay Mukherji
Publikováno v:
Cancer Immunology, Immunotherapy
Adoptive cell therapies with chimeric antigen receptor (CAR) engineered T cells (CAR-T) and immune checkpoint inhibition (ICI)-based cancer immunotherapies have lately shown remarkable success in certain tumor types. CAR-T cell-based therapies target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53fd9faa4491ac1ed27b2a162aa9bd92
http://europepmc.org/articles/PMC5579167
http://europepmc.org/articles/PMC5579167